Evidence map›Paper›PMID 30191513›Full record

ArticleInfection2018

Clinical and microbiological characteristics of adult invasive Haemophilus influenzae infections: results of a 14-year single-center experience from Hungary.

Balint Gergely Szabo, Katalin Szidonia Lenart, Tamas Tirczka, Eszter Ostorhazi

Abstract read
PubMed Publisher
In one paragraph

Article in Infection, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Antibiotic Resistance Profiles ofThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Balint Gergely SzaboDepartment of Infectious Diseases, Saint Ladislaus Campus, South Pest Central Hospital, National Institute of Hematology and Infectious Diseases, Albert Florian ut 5-7, Budapest, 1097, Hungary. szabo.balint.gergely@gmail.com.ORCID http://orcid.org/0000-0003-1775-1356
Katalin Szidonia LenartDepartment of Infectious Diseases, Saint Ladislaus Campus, South Pest Central Hospital, National Institute of Hematology and Infectious Diseases, Albert Florian ut 5-7, Budapest, 1097, Hungary.
Tamas TirczkaNational Public Health Institute, Albert Florian ut 2-6, Budapest, 1097, Hungary.
Eszter OstorhaziInstitute of Medical Microbiology, Semmelweis University, Nagyvarad ter 4, Budapest, 1098, Hungary.
Semmelweis University · HUNational Public Health and Medical Officer Service · HU

Funding

Az orvos-, egészségtudományi- és gyógyszerészképzés tudományos műhelyeinek fejlesztése EFOP-3.6.3-VEKOP-16-2017-00009
6 · The paper itself

Abstract

To describe the characteristics of adult invasive H. influenzae disease, 34 patients diagnosed at a single tertiary center between 2004 and 2017 were analyzed in a retrospective case series study. The annual estimated incidence was 0.1 cases/100.000 inhabitants. Dominant source of infection was pneumonia accompanied by sepsis (62%) and caused by nontypeable strains (74%) with low ampicillin resistance (14%). Survival (94%) and complication rates were high (35%). Main empirical treatments were ceftriaxone or levofloxacine.

Indexed as

Drug Resistance, BacterialAdultAgedAged, 80 and overAmpicillinAnti-Bacterial AgentsCeftriaxoneFemaleHaemophilus InfectionsHaemophilus influenzaeHumansHungaryIncidenceLevofloxacinMaleMiddle AgedAmpicillinAnti-Bacterial AgentsCeftriaxoneLevofloxacinAdult diseaseHaemophilus influenzaeHungaryInvasive disease

Identifiers

PMID30191513
OpenAlexW2889620751

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.